Volume 11, Issue 1, Pages (July 2006)

Slides:



Advertisements
Similar presentations
Jeffrey T Wigle, Guillermo Oliver  Cell 
Advertisements

Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression 
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Determination of Endothelial Stalk versus Tip Cell Potential during Angiogenesis by H2.0-like Homeobox-1  Shane P. Herbert, Julia Y.M. Cheung, Didier Y.R.
Calcification of Multipotent Prostate Tumor Endothelium
Volume 15, Issue 6, Pages (June 2009)
Volume 21, Issue 10, Pages (October 2014)
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice  Ryotaro Hashizume, MD, Aika Yamawaki-Ogata,
Volume 21, Issue 2, Pages (August 2011)
Volume 22, Issue 3, Pages (March 2012)
Hematopoietic cells regulate the angiogenic switch during tumorigenesis by Rika Okamoto, Masaya Ueno, Yoshihiro Yamada, Naoko Takahashi, Hideto Sano, Toshio.
Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis by Yoshihiro Yamada, Nobuyuki Takakura, Hirofumi Yasue, Hisao Ogawa, Hajime Fujisawa,
Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis by Hajime.
by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I
Primitive erythropoiesis from mesodermal precursors expressing VE-cadherin, PECAM-1, Tie2, endoglin, and CD34 in the mouse embryo by Masatsugu Ema, Tomomasa.
Volume 14, Issue 6, Pages (June 2008)
VEGF Gene Delivery to Muscle
David A. Cano, Shigeki Sekine, Matthias Hebrok  Gastroenterology 
Jeffrey T Wigle, Guillermo Oliver  Cell 
Transcriptional Control of Endothelial Cell Development
Volume 35, Issue 6, Pages (September 2002)
Martin Gering, Roger Patient  Developmental Cell 
Malay Haldar, Goutam Karan, Petr Tvrdik, Mario R. Capecchi 
Volume 130, Issue 4, Pages (April 2006)
Volume 33, Issue 4, Pages (May 2015)
Hyunsook Lee, David Kimelman  Developmental Cell 
Volume 18, Issue 5, Pages (May 2003)
A Combinatorial Role of Angiopoietin-1 and Orphan Receptor TIE1 Pathways in Establishing Vascular Polarity during Angiogenesis  Siobhan Loughna, Thomas.
Establishment of Neurovascular Congruency in the Mouse Whisker System by an Independent Patterning Mechanism  Won-Jong Oh, Chenghua Gu  Neuron  Volume.
Volume 10, Issue 3, Pages (March 2006)
Katrin Ottersbach, Elaine Dzierzak  Developmental Cell 
The Placenta Is a Niche for Hematopoietic Stem Cells
Volume 11, Issue 6, Pages (December 2006)
A Role for Hematopoietic Stem Cells in Promoting Angiogenesis
Volume 26, Issue 5, Pages (September 2013)
Robert G. Kelly, Nigel A. Brown, Margaret E. Buckingham 
Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4  Hai U Wang, Zhou-Feng.
Volume 11, Issue 4, Pages (October 2006)
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  Yoichi Miyazaki, Keisuke Oshima,
Sara C. Ahlgren, Marianne Bronner-Fraser  Current Biology 
Volume 7, Issue 1, Pages (July 2004)
Volume 9, Issue 5, Pages (November 1998)
Volume 2, Issue 4, Pages (April 2008)
Volume 16, Issue 6, Pages (June 2009)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 27, Issue 5, Pages (December 2013)
Volume 8, Issue 1, Pages (July 2014)
Establishment of Neurovascular Congruency in the Mouse Whisker System by an Independent Patterning Mechanism  Won-Jong Oh, Chenghua Gu  Neuron  Volume.
Isabella A. Graef, Feng Chen, Lei Chen, Ann Kuo, Gerald R. Crabtree 
Different Consequences of β1 Integrin Deletion in Neonatal and Adult Mouse Epidermis Reveal a Context-Dependent Role of Integrins in Regulating Proliferation,
Volume 3, Issue 3, Pages (September 2002)
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Sonic hedgehog and vascular endothelial growth factor Act Upstream of the Notch Pathway during Arterial Endothelial Differentiation  Nathan D. Lawson,
Volume 23, Issue 2, Pages (August 2012)
Volume 4, Issue 6, Pages (June 2009)
Volume 22, Issue 3, Pages (March 2012)
Volume 18, Issue 4, Pages (April 2010)
Volume 3, Issue 6, Pages (December 2008)
Volume 22, Issue 2, Pages (February 2012)
The Nf1 Tumor Suppressor Regulates Mouse Skin Wound Healing, Fibroblast Proliferation, and Collagen Deposited by Fibroblasts  Radhika P. Atit, Maria J.
Volume 15, Issue 1, Pages (January 2009)
Bonnie E. Lonze, Antonella Riccio, Sonia Cohen, David D. Ginty  Neuron 
FGF Signaling Controls Somite Boundary Position and Regulates Segmentation Clock Control of Spatiotemporal Hox Gene Activation  Julien Dubrulle, Michael.
Volume 8, Issue 4, Pages (April 2005)
Volume 25, Issue 2, Pages (April 2013)
Symmetrical Mutant Phenotypes of the Receptor EphB4 and Its Specific Transmembrane Ligand ephrin-B2 in Cardiovascular Development  Sebastian S Gerety,
Exogenous androstenedione induces formation of follicular cysts and premature luteinization of granulosa cells in the ovary  Yuki Okutsu, M.D., Masanori.
Volume 9, Issue 6, Pages (December 2011)
Volume 10, Issue 11, Pages (March 2015)
Volume 15, Issue 2, Pages (February 2007)
Presentation transcript:

Volume 11, Issue 1, Pages 81-92 (July 2006) HIF-Dependent Hematopoietic Factors Regulate the Development of the Embryonic Vasculature  Diana L. Ramírez-Bergeron, Anja Runge, David M. Adelman, Mercy Gohil, M. Celeste Simon  Developmental Cell  Volume 11, Issue 1, Pages 81-92 (July 2006) DOI: 10.1016/j.devcel.2006.04.018 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Disruption of Vascular Development in Arnt−/− Yolk Sacs and Embryos Whole-mount PECAM stained wild-type embryo (A–C) and yolk sac (G and H) and Arnt−/− embryo (D–F) and yolk sac (I and J). The Arnt−/− embryo lacks proper staining of the cardinal vein ([A and D], black arrowheads), heart ([A and D], white arrows), and pharyngeal pouches as seen in the Arnt+/+ embryo (A and D). Compared to wild-type, the mutant embryo lacks proper inter- and intrasomitic (black arrows, [C and F]) and peripheral (arrowheads, [B and E]) PECAM staining. Striking decreased staining is observed in the AGM region of the Arnt−/− embryo (white dotted lines, [A and B]). Vascular networks, seen as abnormal branching of the vitelline artery in the yolk sac, are deficient in the Arnt−/− embryo (white arrows, [G–J]). Immunohistochemical staining with anti-CD34 of Arnt+/+ (K, M, and O) and Arnt−/− (L, N, and P) 9.5 dpc embryos. The Arnt−/− embryo lacks proper EC staining in the dorsal aorta (M and N, open arrows) and endocardium ([O and P], arrows). Enlarged boxed area demonstrates the presence of CD34+ hematopoietic cells in the Arnt−/− embryo (L). Magnifications: (A) and (D), 120×; (G) and (I), 150×; (B), (C), (E), (F), (H), and (J), 200×; (K) and (L), 100×; (M)–(P), 300×. Developmental Cell 2006 11, 81-92DOI: (10.1016/j.devcel.2006.04.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Impaired Vascular Network Formation by Arnt−/− P-Sp Explants P-Sp regions (white dotted lines) from 9.5 dpc Arnt+/+ (A) and Arnt−/− (B) somite matched embryos were removed and cultured on OP9 stromal cells and immunostained with anti-PECAM (C–F). P-Sp explants from Arnt+/+ embryos (C and D), but not Arnt−/− embryos (E and F), formed extensive PECAM+ vascular beds (white arrowheads) and networks (black arrowheads). In contrast, representative Arnt−/− explants exhibit reduced PECAM staining of tissue outgrowth (E) or a few random PECAM+ cells ([F], open arrowhead). Wild-type explants (G and H) observed in phase contrast micrographs generated extensive nonadherent round hematopoietic cells (arrows), which are lacking in Arnt−/− P-Sp cultures (I and J). Magnifications: (A) and (B), 100×; (C), (E), (G), and (I), scale bar 100 μm; (D), (F), and (J) 100×; (H), 200×. Developmental Cell 2006 11, 81-92DOI: (10.1016/j.devcel.2006.04.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Wild-Type Sca-1+GFP+ Bone Marrow Cells Rescue Arnt−/− P-Sp Explants Sca-1+ cells isolated from the bone marrow of wild-type GFP+ mice were added to P-Sp explant cultures and stained for PECAM after 14 days (C–F). As a control, representative untreated Arnt+/+ (A) and Arnt−/− (B) P-Sp cultures are shown. Rescued vascular networks (asterisk) from Arnt−/− explants (C–F) were comparable to wild-type controls (A). (G) Measurements of lengths from ten individual vessels extending from the vascular beds expressed as mean ± SEM distance from five independent wild-type (gray) and mutant (white) rescued explants. As a control (pound sign), the mean ± SEM from an untreated Arnt−/− culture with minimal vessel staining (B) is shown. The horizontal lines represent average vessel lengths for the Arnt+/+ and Arnt−/− cultures (p ≤ 0.98). (H) DiI-Ac-LDL uptake of endothelial cells from a rescued P-Sp culture showing a peripheral ring of cells that includes the vascular networks. (I) Higher magnification showing no overlap between the DiI-Ac-LDL+ ECs originating from the explant and the GFP+ hematopoietic donor cells in rescued cultures. (J–M) Higher magnification phase contrast (J and L) and counterpart green fluorescent (K and M) micrographs demonstrating track of ECs (dotted white lines) that do not incorporate GFP+ cells. (N–Q) Higher magnification phase contrast (N and P) and green fluorescent (O and Q) micrographs demonstrating nonadherent hematopoietic colonies that are GFP− arising from the rescued explants. Magnifications: (A)–(F), scale bar 100 μm; (H), 100×; (J)–(K), 400×; (I) and (L)–(Q), 200×. Developmental Cell 2006 11, 81-92DOI: (10.1016/j.devcel.2006.04.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Reduced VEGF Levels in Arnt−/− Embryos Result in Increased Hematopoietic Cell Death (A) VEGF protein levels are reduced in Arnt−/− 9.5 dpc embryos. Transverse sections of Arnt+/+ (Aa–Ac) and Arnt−/− (Ad–Af) embryos probed for Vegf (Ab and Ae) and Pgk (Ac and Af) showing no overall differences in expression. As a comparison, hematoxylin-stained Arnt+/+ (Aa) and Arnt−/− (Ad) serial sections are shown. VEGF immunohistochemistry of transverse sections of 9.5 dpc (28 somites) Arnt+/+ (Ag) and Arnt−/− (Ah) embryos showing reduced protein expression in the mutant embryo. Expression is particularly reduced in the hematopoietic compartment (higher magnification inlay) of the Arnt−/− embryo (arrow). Dorsal aorta, da; hematopoietic cells, HCS; heart, ht; neural tube, nt. (Ai) VEGF levels from whole-cell or postnuclear lysates of individual 9.5 dpc (21 somites) Arnt+/+ (black) and Arnt−/− (white) embryos analyzed by ELISA. Error bars indicate standard error of the mean (n = 3; ∗p < 0.005). (B) Increased apoptosis in Arnt−/− embryos. TUNEL immunostaining (FITC, green) of transverse sections counterstained with hematoxylin (Ba and Bb) or nuclear DAPI (blue) (Bc and Bd) and hematoxylin-stained sagittal sections (Be and Bf) of Arnt+/+ (Ba, Bc, and Be) and Arnt−/− (Bb, Bd, and Bf) embryos. An increase in TUNEL+ HCs was detected in the dorsal aorta ([Bd], arrowheads) of Arnt−/− transverse sections compared to the modest TUNEL staining observed in the Arnt+/+ control (Bc). Increased numbers of TUNEL+ cells in the dorsal aorta ([Bf], arrows) and intrasomitic ([Bf], dotted lines) regions are observed in Arnt−/− sagittal sections. Comparison of apoptotic cells in the dorsal aortic region of Arnt+/+ (black) and Arnt−/− (white) transverse sections (Bg). Numbers of apoptotic cells are expressed as total numbers of FITC+ cells; ∗p < 0.005. Magnifications: (Aa)–(Af), (Ba), (Bb), (Be), and (Bf), 50×; (Ag)–(Ah), (Bc), and (Bd), 100× (inserts 400×). Developmental Cell 2006 11, 81-92DOI: (10.1016/j.devcel.2006.04.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 VEGF Is Required for P-Sp Explant Blood Vessel Development (A) Treatment of P-Sp explants with VEGF or Ang-1 promotes vessel growth. Addition of 100 ng/ml VEGF to Arnt−/− cultures (Ac and Ad) promotes fine patterning and branching in the vascular networks (asterisk). Arnt+/+ cultures (Aa and Ab) are shown as controls. Addition of 300 ng/ml Ang-1 does not result in proper angiogenesis but promotes congestion (∧) in the vascular networks in Arnt−/− cultures (Ag and Ah) as well as the Arnt+/+ P-Sps ([Ae and Af], p < 0.722). However, the congestion was worse in the Arnt−/− explants. Addition of 300 ng/ml of Flt-1-Fc (Aj–Al) inhibited proper vessel development as compared to control (Ai) P-Sp explants. All explants were stained for PECAM. Magnifications: scale bars 100 μm. (B) Measurement of vessel areas from VEGF- or Ang-1-treated P-Sp explants. Ten sprouting vessel measurements from five independent Arnt−/− and Arnt+/+ P-Sp explants were analyzed. Results are shown as mean vessel lengths (±SEM) for wild-type (black) and mutant (white) VEGF-treated or Ang-1-treated explants. Note that Ang-1 promoted vessel congestion. (C) Proper vessel development requires HIF-dependent factors supplied by hematopoietic cells. Differentiation of hematopoietic cells and vasculature is HIF dependent during three separate events. (1) HIF promotes the survival of hematopoietic cells. (2) Hematopoietic cells serve as a paracrine source of VEGF, which induces vasculogenesis by increasing the production and proliferation of endothelial cells. (3) Hematopoietic cells are also a source of Ang-1, promoting angiogenesis, as measured by the remodeling and maturation of vessels (Takakura et al., 2000). Loss of Arnt results in HIF deficiency, increased numbers of apoptotic cells in the hematopoietic compartment, and a reduction of VEGF production. Developmental Cell 2006 11, 81-92DOI: (10.1016/j.devcel.2006.04.018) Copyright © 2006 Elsevier Inc. Terms and Conditions